Department of Immunology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht Str. 74, 20359 Hamburg, Germany.
Vaccine. 2012 Jan 20;30(5):862-71. doi: 10.1016/j.vaccine.2011.11.110. Epub 2011 Dec 13.
The control of strongyloidiasis affecting approximately 100 million people - caused by the gastrointestinal nematode Strongyloides stercoralis - is still based on anti-helminthic treatment. In the current study we analysed the immune response to Strongyloides ratti heat shock protein 60 (srHSP60) as a possible vaccine candidate in the murine system. We show that srHSP60 is a target of both, humoral and cellular response in S. ratti-infected mice. Strikingly, vaccination with srHSP60 without adjuvant or with CFA induced a S. ratti-specific Th1 response in vivo that did not confer protection but slightly increased larval output during challenge infection. Using in vitro T cell stimulation assays we provide further evidence that srHSP60 skewed activated T cells towards a Th1 response that interfered with efficient clearance of S. ratti infection. Vaccination with alum-precipitated srHSP60, in contrast, overruled the Th1-inducing activity intrinsic to srHSP60, induced a Th2 response, and conferred partial protection against a challenge infection. As srHSP60 is actively secreted by S. ratti during all life stages, our findings strongly suggest that srHSP60 induced polarization towards a Th1 response reflects a mechanism of immune evasion by this pathogenic nematode.
控制影响约 1 亿人的旋毛虫病 - 由胃肠道线虫旋毛虫引起 - 仍然基于抗蠕虫治疗。在目前的研究中,我们分析了对 Strongyloides ratti 热休克蛋白 60(srHSP60)的免疫反应,作为鼠系统中的一种可能的疫苗候选物。我们表明,srHSP60 是 S. ratti 感染小鼠中体液和细胞反应的靶标。引人注目的是,srHSP60 疫苗接种,无论是无佐剂还是 CFA 诱导,都会在体内诱导 S. ratti 特异性 Th1 反应,该反应不能提供保护,但在挑战感染期间略微增加幼虫产量。通过体外 T 细胞刺激测定,我们进一步提供了证据表明,srHSP60 将激活的 T 细胞偏向 Th1 反应,从而干扰 S. ratti 感染的有效清除。相比之下,用明矾沉淀的 srHSP60 接种疫苗,推翻了 srHSP60 固有的 Th1 诱导活性,诱导了 Th2 反应,并对挑战感染提供了部分保护。由于 srHSP60 在所有生命阶段都由 S. ratti 主动分泌,因此我们的发现强烈表明,srHSP60 诱导的 Th1 反应极化反映了这种致病线虫的免疫逃避机制。